Marc Carrier/X
Jun 22, 2025, 06:29
Marc Carrier: Therapeutic Anticoagulation Improves Survival in Non-Critical COVID-19
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on X.
“In non-critically ill patients with COVID-19, therapeutic-dose anticoagulation reduced organ support, thrombosis, and death by 28 days, but increased bleeding risk (though absolute risk stayed low).
No high-credibility effect modifiers found.
Great work.”
More ISTH 2025 posts on Hemostasis Today.
-
May 27, 2026, 15:43Aryabhatta Sadhu: Effective Hemotherapy Beyond Transfusion
-
May 27, 2026, 15:38Wolfgang Miesbach: How Haemophilia Care Has Evolved in China
-
May 27, 2026, 15:27Saja Abo Thyab: How MDS Can Progress to AML
-
May 27, 2026, 15:25Ifeanyichukwu Ifechidere: Coagulation Detective Case – The Prolonged APTT Mystery
-
May 27, 2026, 15:23Rushikesh Raut: Understanding Pancytopenia in Medical Coding
-
May 27, 2026, 15:19Dip Ghosh: Understanding Blood – From Sample to Diagnosis
-
May 27, 2026, 15:14Jeremiah Bernier-Latmani: Could Angpt2 Blockade Become a New Treatment for GI Bleeding in VWD
-
May 27, 2026, 15:11Paolo Zamboni: How Female Steroid Metabolism Triggers Lipedema?
-
May 27, 2026, 14:56Veronica Sanchez: Risk Factors and How to Recognize the Signs of Preeclampsia